1. Introduction {#s0005}
===============

Aging is accompanied by concurrent declines in visual and brain functions. Studies in humans and animal models provide converging evidence that these functional changes are often accompanied by specific structural alterations of the eye and brain regions ([@bb0115]; [@bb0085]; [@bb0060]). The eyes and brain are anatomically and functionally connected ([@bb0155]). On the one hand, the retina and optic nerve are extensions of the brain that can be directly observed from the surface of the body. On the other hand, as visual information accounts for a large proportion of brain inputs, visual skills, such as stereopsis and form perception, are highly and consistently correlated with intellectual development ([@bb0065]).

Ocular diseases have been shown to contribute to cognitive decline and abnormal changes in brain structure. Subjects with untreated poor vision showed a 5- to 9·5-fold increased risk of developing Alzheimer\'s disease (AD) or other cognitive disorders ([@bb0190]). Impairment of the brain\'s short-range and long-range functional connections in visual pathways, the frontal cortex, visual areas, posterior parietal, and frontal cortices was also detected in children with anisometropic amblyopia ([@bb0220]). Furthermore, widespread structural abnormalities in the central nervous system extending beyond the visual cortex were observed in patients with advanced primary open-angle glaucoma, an irreversible disease involving the retina and optic nerve ([@bb0035]).

Age-related cataract (ARC), the most common cause of vision decline or loss in the general aging population, is due to lens opacification ([@bb0010]). A retrospective study in Taiwan of 19,954 ARC patients revealed a marked increase in the overall incidence of AD after an 8-year follow-up, suggesting that ARC is associated with structural and functional impairments of the brain ([@bb0120]). The vision loss of most cataract patients can be readily corrected via phacoemulsification and intraocular lens (IOL) implantation. However, whether functional and structural changes in the brain can be reversed after visual restoration is largely unknown. Previous studies have reported cognitive improvements in elderly patients after cataract surgery ([@bb0200]; [@bb0100]). However, most of these functional analyses were based on subjective questionnaire investigations and lacked objective evidence, such as neuroimaging. Furthermore, whether ocular reconstruction can promote functional and structural changes in specific brain regions remains unclear.

In the present study, we conducted a prospective, controlled clinical trial with consecutive patients presenting bilateral ARC. These patients exhibited significantly decreased visual function and underwent phacoemulsification with IOL implantation. We measured changes in brain function and structure before and after cataract surgery using functional magnetic resonance imaging (fMRI), a well-established neuroimaging technology that not only evaluates grey matter (GM) variation but also detects functional changes in the brain by monitoring blood oxygen level-dependent signals ([@bb0195]), and the Mini-Mental State Examination (MMSE), a classic measurement of cognitive impairment ([@bb0170]; [@bb0045]). We demonstrate that patients with ARC display impaired brain function and structure, but these changes can be fully reversed by visual acuity restoration.

2. Materials and Methods {#s0010}
========================

2.1. Participants and Study Design {#s0015}
----------------------------------

Twenty-six patients (13 males and 13 females) with ARC and 26 healthy controls matched for age, sex, and education, were recruited from Zhongshan Ophthalmic Center (ZOC). Written informed consent was obtained from all participants or their legal guardians. This study was approved by the Ethics Committee of ZOC at Sun Yat-sen University and followed the tenets of the Declaration of Helsinki. Twenty-six patients (52 eyes) were allocated to the Tecnis ZMB00 IOL (Abbott Medical Optics, Santa Ana, CA, USA) or ZCB00 IOL (Abbott Medical Optics, Santa Ana, CA, USA) arms depending on the patient\'s choice. The inclusion criteria for the study were as follows: cataracts in both eyes classified according to the Lens Opacity Classification System III, corneal astigmatism \< 1·0 diopters (D), and IOL power between +18·0 and +25·0 D. The exclusion criteria included a medical history of neurological or psychiatric disorders, prior refractive, glaucoma, or penetrating keratectomy surgery, degenerative optical diseases, associated ocular or systemic diseases that may interfere with the results, significant vitreous loss during surgery that may hamper the implantation and performance of IOLs, and anterior chamber hyphema. Cataract surgery was performed in all patients by the same experienced ophthalmologist (WRC). The standard technique in all patients consisted of sutureless phacoemulsification using a Legacy 2000 Series and Infinity phacoemulsification machine (Alcon Laboratories Inc., Fort Worth, Texas, USA), with clear corneal incisions up to 3·2 mm and 5·0 to 5·5 mm capsulorhexis. Surgery was performed on the second eye 1 month after the first procedure in each patient. Structural and functional MRI scans were performed before surgery and at 1 week, 3 months, and 6 months after surgery on the second eye ([Fig. 1](#f0005){ref-type="fig"}). This trial was registered with [ClinicalTrials.gov](http://ClinicalTrials.gov){#ir0015}, [NCT02644720](ctgov:NCT02644720){#ir0020}.Fig. 1Flowchart of recruitment and follow-up evaluations from 1 week after the second eye surgery. Notes: fMRI, functional magnetic resonance imaging; MMSE, Mini-Mental State Examination; UCDVA, uncorrected distance visual acuity; BCDVA, best-corrected distance visual acuity; CS, contrast sensitivity; SVs, straylight values; VEP, visual evoked potential; IOL, intraocular lens; SIOL, single-focus intraocular lens; MIOL, multifocal intraocular lens.Fig. 1

2.2. Examination of Ocular Structure and Visual Function {#s0020}
--------------------------------------------------------

At the 6-month follow-up visit, a slit-lamp examination was performed to examine the transparency of the posterior capsule and to exclude residual posterior capsule plaques. The locations of the IOLs were recorded by a slit lamp (BX900; HAAG-STREIT AG, Bern, Switzerland) examination and a 3-dimensional anterior segment imaging and analysis system (Pentacam HR; Oculus, Inc., Wetzlar, Germany). Distance visual acuity was examined with a Standard Logarithmic Visual Acuity E chart (Snellen). UCDVA (LogMAR) and BCDVA (LogMAR) were recorded preoperatively and at 1 week, 3 months, and 6 months postoperatively. For the correlation analysis between VA (UCDVA and BCDVA) and the fALFF value and GM volume, the VA data were calculated by averaging the binoculus.

Retinal SV measurements were obtained with a C-Quant straylight meter (Oculus Optikgerate GmbH, Wetzlar, Germany) ([@bb0150]). The patient viewed a series of concentric areas. The smallest area in the center was divided into two halves. This area was the test field where the patient was asked to look when a concentric ring flickered with varying intensity. The flickering in the straylight source produced a certain amount of perceived flickering in the test field. The patient was asked to compare the two halves of the test field, one of which included additional counter-phase flickering, and to choose the side that flickered more strongly by pressing a button. The selected side defined a psychometric function from which the SV was obtained.

The PVEP was recorded using an Espion system (Diagnosys LLC, Lowell, MA, USA) in accordance with the International Society for Clinical Electrophysiology of Vision (ISCEV) recommendations ([@bb0160]). Frontal (Fz)-occipital (Oz) electrode placement was performed. Patient refractions were corrected with trial lenses using the international standard visual acuity chart before the PVEP was examined. All patients were instructed to maintain fixation at the center of a stimulus located at a distance of 1 m in front of a 20 × 30 cm black-and-white video display monitor (contrast 99%). The reversal rate was 1 reversal per second. The checkerboard stimulus subtended a visual angle of 5·7° vertically and 8·5° horizontally on either side of the fixation point. The P100 amplitude and latency for checkerboard sizes (15 min of arc) were recorded. An experienced electrophysiology technician closely monitored the fixation stability of the eyes. If the patient was not cooperative, the PVEP examination was repeated. All PVEP examinations were performed under the same laboratory conditions. For the correlation analysis between the peak time or amplitude and the fALFF value or GM volume, the average value for the binoculus was calculated.

CS was tested with a Contrast Glare Tester 1000 ([@bb0175]) (CGT-1000 Takagi Seiko Co., Ltd., Nagano, Japan) at 1 week, 3 months, and 6 months postoperatively. This instrument accurately determines CS in a simple and rapid fashion. The contrast threshold was presented at 12 levels, from 0·01 to 0·45, and was determined using a staircase procedure similar to that used in automatic visual field tests. The test was conducted at a distance of 35 cm from the screen and lasted approximately 1 min per eye. The patient was required to press a button only when he or she observed the stimulus. CS function was always determined by measuring best-corrected visual acuity to prevent residual refractive errors from affecting the CS value. The absolute value of log CS was used in the statistical analysis. For the correlation analysis between fALFF values and CS, the CS data were collapsed into a single index using the weighted mean contrast sensitivity (WMCS), which is defined as the mean of the data for each spatial frequency multiplied by the corresponding contrast sensitivity ([@bb0125]).

2.3. Evaluation of Cognitive and Brain Functions {#s0025}
------------------------------------------------

MMSEs were performed to evaluate cognitive function by trained clinical physicians. The MMSE contains 5 sections (orientation, registration, attention and calculation, recall and language). A higher MMSE score indicates better cognitive conditions (range 0 to 30). MRI evaluations were carried out using a MAGNETOM Verio 3 T MR scanner (A Tim System; Siemens, Erlangen, Germany). Resting-state fMRI scans were performed using an echo planar imaging sequence with the following parameters: repetition time = 3000 ms, echo time = 30 ms, flip angle = 90°, matrix = 64 × 64, field of view = 192 × 192 mm^2^, slice thickness = 3 mm, and slice gap = 0·5 mm. Each brain volume was composed of 41 axial slices, and each functional run contained 124 volumes. During the scans, all subjects were instructed to look forward through the center of the mirror, fix their vision in that direction and minimize movement. Tight but comfortable foam padding was used to minimize head motion, and earplugs were used to reduce scanner noise. All subjects confirmed that they did not fall asleep during scanning. Structural T1-weighted images were acquired in the sagittal orientation using a magnetization-prepared rapid gradient echo imaging sequence with the following parameters: repetition time = 1900 ms, echo time = 2·52 ms, flip angle = 9°, acquisition matrix = 256 × 256, field of view = 250 × 250 mm^2^, and 176 total images with 1-mm-thick slices. The scanning time was 258 s.

2.4. Data Preprocessing {#s0030}
-----------------------

Standard data processing software, Data Processing Assistant for Resting-State fMRI (DPARSF 2·2; <http://restmri.net/forum/DPARSF>), was used for the analysis of resting-state data. DPARSF is a plug-in software that runs on a matrix laboratory platform (MATLAB R2010b; MathWorks, Inc., Natick, MA, USA) and is based on Statistical Parametric Mapping (SPM8; <http://www.fil.ion.ucl.ac.uk/spm>). The preprocessing steps were as follows: the first 10 time points were discarded to avoid transient signal changes before the magnetization reached a steady state. Subjects with \>1·5-mm maximum displacement in any dimension and 1·5° of angular motion during the entire fMRI were removed from the data analysis. No subjects were eliminated at this step. The head-motion courses were also compared among the four groups using repeated measures analysis of variance, which revealed no significant differences. The head-motion measurements were set as covariates for group-level comparisons. Slice timing and spatial realignment were performed. Following motion correction, all data were normalized to the Montreal Neurological Institute (MNI) space using echo planar imaging templates and resampling to 3-mm isotropic voxels. The normalized data were processed with the removal of linear trends and were temporally filtered (band pass, 0·01--0·08 Hz) to remove the effects of very-low-frequency drift and physiological high-frequency respiratory and cardiac noise. The structural MRI data were preprocessed and analyzed using Statistical Parametric Mapping software (SPM8, Wellcome Trust Centre for Neuroimaging, London, UK) implemented in MATLAB 7.11.0 (MathWorks, Natick, MA, USA). We used the VBM8 toolbox ([http://dbm.neuro.uni-jena.de/vbm8/](http://dbm.neuro.uni-jena.de/vbm8){#ir0035}) with the longitudinal data approach batch. After a quality evaluation of the data, we manually reoriented the images to the anterior commissure. The VBM8 longitudinal batch had specific preprocessing steps for longitudinal data; the data from each subject were registered to the baseline image (or mean image), and spatial normalization parameters were estimated for only the baseline image and applied to all images. We used the "modulated normalized" and "non-linear only" options, resulting in tissue class images aligned with the template in which the voxel value was multiplied by the non-linear components. After segmentation, the GM and white matter volumes were entered into an iterative study-specific normalization procedure based on Diffeomorphic Anatomical Registration using Exponentiated Lie algebra. After normalization, the study-specific GM template was co-registered to a corresponding MNI space GM template using an affine transformation. GM segmentations for individual subjects were then normalized to the MNI space and modulated to preserve GM amounts during normalization and smoothed with an isotropic 6-mm full width at half-maximum Gaussian kernel.

2.5. fALFF Analysis {#s0035}
-------------------

fALFF analysis was performed using the Resting-State fMRI Data Analysis Toolkit (REST 1·8; <http://www.restfmri.net>). The time series for each voxel was transformed to the frequency domain using fast Fourier transform (FFT) (parameters: taper percent = 0 and FFT length = shortest), and the power spectrum was obtained, square-rooted and then averaged across 0·01 to 0·08 Hz at each voxel. This averaged square root was considered the ALFF. The fALFF was used as a normalized index of ALFF by providing the relative amplitude of the low-frequency domain against the entire spectrum of frequencies ([@bb0225]; [@bb0040]), which may effectively suppress physiological artifacts. Finally, all fALFF images were smoothed using a Gaussian kernel with a full width at a half-maximum of 6 mm.

2.6. Regions of Interest(ROI) Definition {#s0040}
----------------------------------------

Automated ROI was created using orthogonal contrasts in a factorial design. Exploratory ROIs were created by placing small spheres at local maxima in the statistical map. This was a post-processing method that used statistical parametric maps. To ensure that benefits from the proposed method were not due to the statistical parametric maps themselves, we performed two-sample *t*-tests or repeated measures analyses of variance based on the BOLD signal or GM volume changes to obtain the statistical parametric maps. The voxels in the statistical maps were then labeled by the appropriate ROIs drawn on the anatomical image.

2.7. Statistical Analysis {#s0045}
-------------------------

Data were entered the Statistical Package for the Social Sciences (SPSS ver. 19·0, Chicago, IL, USA) for statistical analysis. For visual function, a mixed design analysis of variance (ANOVA) was performed to evaluate the differences between the cataract and control groups and the changes observed before and after cataract surgery (binocular data). Independent sample *t*-tests were performed to examine the differences in age, sex, and MMSE scores between the cataract and control groups. For brain function, two-sample *t*-tests were performed to evaluate the differences in fALFF values between the cataract and control groups and the changes across time points after surgery. Repeated measures analyses of variance were used to evaluate the changes in MMSE scores and fALFF values preoperatively and postoperatively. The resulting statistical maps were set at a combined threshold of *P* \< 0·05 with a minimum cluster size of 228 voxels, which corresponded to the corrected threshold of P \< 0·05 determined by AlphaSim. For brain structure, two-sample *t*-tests were performed to evaluate the differences in GM volume between the cataract and control groups and the changes across time points after surgery (at a whole-brain threshold of P \< 0·05, False Discovery Rate (FDR) corrected, voxels \> 20), and repeated measures analyses of variance were used to analyze the changes before and after cataract surgery and the changes across time points after surgery (at a whole-brain threshold of P \< 0·01, False Discovery Rate (FDR) corrected, voxels \> 200).

3. Results {#s0050}
==========

3.1. Demographics of the Patients in the Prospective, Controlled Clinical Trial {#s0055}
-------------------------------------------------------------------------------

Twenty-six patients (13 males and 13 females) with ARC and 26 healthy controls without ARC, matched for age, sex, and education (a longer education duration is associated with a thicker cortex across several loci and a reduced risk of cognitive decline ([@bb0030])), were recruited for our study. The mean age of the 26 patients in the cataract group was 63·81 ± 7·11 years (ranging from 47 to 72 years). The mean age of the 26 healthy subjects in the control group was 62·04 ± 6·83 years (ranging from 48 to 74 years). No significant differences were noted in terms of age, sex, and education between the cataract and control groups (*P* \> 0·05, Cohen\'s d = 0·25; P \> 0·05, Cramer\'s V = 0; P \> 0·05, Cramer\'s V = 0).

In the cataract group, 8 patients were implanted with a single-focus intraocular lens (SIOL), and 18 patients were implanted with a multifocal intraocular lens (MIOL) (SI Appendix, Fig. S1). For the subgroup analysis between SIOLs and MIOLs, please refer to Supplementary Results.

3.2. Simultaneous Functional Decline and Structural Changes in the Eyes and Brains of Patients With ARC {#s0060}
-------------------------------------------------------------------------------------------------------

### 3.2.1. Changes in Visual Function and Ocular Structure {#s0065}

The lenses of the cataract patients exhibited increased density and decreased transparency compared to those of the control group (SI Appendix, Fig. S2a). Additionally, the cataract group exhibited significantly lower UCDVA, logarithm of the minimum angle of resolution \[LogMAR\] than the control group (0·80 ± 0·42 vs. −0·02 ± 0·03, *P* \< 0·001, Cohen\'s d = 0·275) (SI Appendix, Fig. S2b). Moreover, the cataract group showed a significantly longer peak time and lower P100 amplitude of PVEP than the control group (124·63 ± 14·59 vs. 106·80 ± 7·10 ms \[peak time\] (*P* \< 0·001, Cohen\'s d = 1·55) and 7·95 ± 3·95 vs. 13·02 ± 6·80 μV \[amplitude\] (P \< 0·001, Cohen\'s d = 0·911) (SI Appendix, Fig. S2c and d).

### 3.2.2. Changes in Neurocognitive Function {#s0070}

The MMSE is an international standard for evaluating intelligence state and cognitive impairment in patients with cognitive disorders ([@bb0170]; [@bb0050]). The cataract group exhibited a significantly lower MMSE score (27·65 ± 1·47) than the control group (29·58 ± 0·86) (*P* \< 0·001, Cohen\'s d = 1·60) ([Fig. 2](#f0010){ref-type="fig"}a). Next, we analyzed fALFF to quantify the intensity of regional spontaneous brain activity. In cataract patients, a decreased fALFF value was detected in areas related to vision and attention (superior occipital lobule and superior parietal lobule) and cognition (precuneus), with peak voxels detected in the inferior parietal lobule. By contrast, the fALFF value in the brainstem was significantly increased in the cataract group compared with that in the control group ([Fig. 2](#f0010){ref-type="fig"}b, c, d and [Table 1](#t0005){ref-type="table"}). The fALFF values in the inferior parietal lobule of the control group and the cataract group were 0·15 ± 0·05 and 0·07 ± 0·06, respectively (*P* \< 0·05, Cohen\'s d = 1·45). The fALFF values in the brainstem of the control group and the cataract group were −0·15 ± 0·09 and −0·06 ± 0·11, respectively (*P* \< 0·05, Cohen\'s d = 0·90).Fig. 2Comparison of brain function and structure between the control and cataract groups before surgery. a, MMSE scores of the control and cataract groups were recorded (*P* \< 0·001, independent sample *t*-test). b, Surface maps show the changes in the fALFF values between the controls and patients with cataract (at a whole-brain threshold of *P* \< 0·05, AlphaSim corrected, voxels \> 228, two-sample *t*-test). c, d, Slice overlays and plots represent the mean signal from the smoothed difference images for each cluster. Significant differences in signals between the control group and the cataract group are highlighted within the red circle. Blue and cyan reflect decreases in the superior parietal lobule, superior occipital lobule, and precuneus with peak voxels observed in the inferior parietal lobule. Red and yellow reflect increases in the brainstem, and *t* indicates the peak *t*-score value for the *t*-test. e, Surface maps show the changes in GM volume between the controls and the patients with cataract. f, Slice overlays and plots represent the mean signals from the smoothed difference images for each cluster. Significant differences in signals between the control group and the cataract group are highlighted within the red circle. Blue and cyan reflect decreases in the anterior cingulate gyrus, and *t* indicates the peak *t*-score value for the *t*-test. Notes: Dotted lines indicate the mean value; MMSE, Mini-Mental State Examination; fALFF, fractional amplitudes of low-frequency fluctuation; L, left; Inf, inferior; GM, grey matter; Ant. anterior.Fig. 2Table 1Comparison of fALFF values between the control group and the cataract group before and after surgery.Table 1ContrastsRegionsBACluster size (voxels)MNI Coordinates*t*-Score for peak voxelsxyzCataract vs. ControlSuperior parietal lobule (L), superior occipital lobule, precuneus7/19304−18−7848−4·0796Brainstem433−6−21−243·8526Post-1 w vs. Pre--Post-3 m vs. PreBrainstem95718−33−36−3·779Cerebellum posterior lobe (L)247−36−60−48−3·3208Post-6 m vs. PreSuperior parietal lobule (L)7/19845−18−78484·5655Brainstem731−6−21−24−3·9227[^3]

### 3.2.3. Changes in Brain Structure {#s0075}

GM is a major component of the central nervous system, mainly consisting of neuronal cell bodies and unmyelinated axons ([@bb0185]). Changes in GM volumes are generally used to represent alterations in brain structure ([@bb0180]). The extracted GM value for the anterior cingulate gyrus (cognitive area) as ROI was significantly lower in the cataract group than that in the control group (0·35 ± 0·03 vs. 0·41 ± 0·03, *P* \< 0·05, Cohen\'s d = 2·00) ([Fig. 2](#f0010){ref-type="fig"}e, f and [Table 2](#t0010){ref-type="table"}).Table 2Comparison of GM volumes between the control group and the cataract group before and after surgery.Table 2ContrastsRegionsBACluster size (voxels)MNI coordinates*t*-Score for peak voxelsxyzCataract vs. ControlAnterior cingulate gyrus2429−1·524−4·5−6·3667Post-1 w vs. Pre--Post-3 m vs. PrePost-6 m vs. PreFrontal Inf. Orb (R)38/47643334·524−126·433Fusiform (L)20/36246−25·5−3−40·54·9275Frontal Inf. Orb (L)471957−2110·5−19·56·0618Superior temporal gyrus (L)21/221920−49·5−3−4·56·159Frontal Med. Orb (L)10241−4·554−35·3166Calcarine (L)18/19/30506−12−61·510·55·052Calcarine (R)18/3021618−5795·0549Anterior cingulate gyrus (R)9/32911642276·3945Middle frontal gyrus (L)6/8/9631−43·512425·989Middle frontal gyrus (R)6/8/964131·512575·3926Middle cingulate gyrus (R)316601·5−45335·0194Precentral gyrus (R)452331·5−25·5574·9598Postcentral gyrus (L)4521−46·5−13·549·54·6004Precentral gyrus (L)6583−30−6485·4285[^4]

3.3. Functional Visual Improvement After Optical Reconstruction {#s0080}
---------------------------------------------------------------

In the cataract group, the UCDVA values (0·80 ± 0·42) were significantly increased at 1 week (0·04 ± 0·08) (P \< 0·001, Cohen\'s d = 2·51), 3 months (0·01 ± 0·07) (P \< 0·001, Cohen\'s d = 2·62) and 6 months (0·01 ± 0·07, Cohen\'s d = 2·62) postoperatively. The best-corrected distance visual acuity (BCDVA) values (0·63 ± 0·41) were also significantly increased at 1 week (−0·04 ± 0·04), 3 months (−0·04 ± 0·04), and 6 months (−0·04 ± 0·04) postoperatively (P \< 0·001, Cohen\'s d = 2·30) (SI Appendix, Fig. S3a, b, and SI Appendix, Table S1). Straylight measurement has been used to objectively evaluate the quality of vision ([@bb0215]). Compared with the value observed at 1 week postoperatively (1·39 ± 0·22), the retinal SV of log(s) was significantly decreased at 3 months (1·29 ± 0·18) (P \< 0·05, Cohen\'s d = 0·50), and 6 months (1·23 ± 0·18) (P \< 0·05, Cohen\'s d = 0·80) postoperatively, indicating a steady improvement in visual function (SI Appendix, Fig. S3c).

Additionally, the P100 amplitude was significantly increased (P \< 0·001, Cohen\'s d \> 0·8) postoperatively, and the peak time was significantly decreased (P \< 0·001, Cohen\'s d \> 1·2) (SI Appendix, Fig. S3d and e). CS measurement is a sensitive method used to assess visual function in post-surgery cataract patients ([@bb0210]). Compared with the value observed at 1 week postoperatively, the log CS value observed at 3 or 6 months postoperatively was significantly increased (P \< 0·05, Cohen\'s d \> 0·5) (SI Appendix, Fig. S3f). Collectively, these data showed that the visual function of cataract patients was significantly improved after surgery.

3.4. Cognitive Functions and Brain Recovery After Visual Restoration {#s0085}
--------------------------------------------------------------------

A previous study has shown that after cataract surgery, patients exhibited increased MMSE scores that were positively correlated with improvement of visual acuity ([@bb0100]). Consistently, we observed that the registration, recall, attention, and calculation scores as well as the total MMSE scores were significantly increased at 3 and 6 months postoperatively compared with those at the preoperative time point (SI Appendix, Table S2). Additionally, we detected a significant decrease in the fALFF value in the brainstem and cerebellum regions 3 months postoperatively ([Fig. 3](#f0015){ref-type="fig"}a, b and [Table 1](#t0005){ref-type="table"}). Six months postoperatively, the fALFF value was significantly increased in the vision-related areas (superior parietal lobule), but decreased in the brainstem ([Fig. 3](#f0015){ref-type="fig"}c and [Table 1](#t0005){ref-type="table"}). Compared with the control group, an increased fALFF value in the brainstem but a decreased fALFF value in the superior parietal lobule (L) were noted at 1 week postoperatively (SI Appendix, Fig. S4a, SI Appendix, Table S3). Increased fALFF values in the precentral and postcentral gyrus were also detected 3 months postoperatively (SI Appendix, Fig. S4b, SI Appendix, Table S3). However, no significant differences were observed in the fALFF values between the patients at 6 months postoperatively and the controls (SI Appendix, Fig. S4c, SI Appendix, Table S3). These findings indicate that after cataract surgery, brain functions in cognitive and visual-related areas can be specifically enhanced and fully reversed to the normal level.Fig. 3Comparison of brain function in cataract patients before and after surgery. Surface maps show the fALFF value changes between preoperative and postoperative time points (at a whole-brain threshold of P \< 0·05, AlphaSim corrected, voxels \> 228, repeated measures analysis of variance). Slice overlays and plots represent the mean signals from the smoothed difference images for each cluster. Significant differences in signals are highlighted in the red circles. Blue and cyan reflect decreases. Red and yellow reflect increases, and *t* indicates the peak *t*-score value for the *t*-test. a, No significant difference in fALFF signals was detected between the preoperative and 1 week postoperative time points. b, The fALFF values were significantly decreased in the brainstem and cerebellum at 3 months postoperatively. c, The fALFF values were significantly decreased in the brainstem but increased in the superior parietal lobule 6 months postoperatively. Notes: L, left; Sup., superior.Fig. 3

3.5. Structural Brain Recovery After Visual Restoration {#s0090}
-------------------------------------------------------

No significant difference in GM volume was noted between the preoperative time point and 1 week and 3 months postoperatively ([Fig. 4](#f0020){ref-type="fig"}a, b and [Table 2](#t0010){ref-type="table"}). However, significantly increased GM volume was observed 6 months postoperatively, specifically in the visual-related areas (calcarine), cognition-related areas (anterior cingulate gyrus), somatosensory-related areas (postcentral gyrus), somatic motor-related areas (precentral gyrus), and other areas (fusiform, inferior/middle frontal gyrus, and superior temporal gyrus) ([Fig. 4](#f0020){ref-type="fig"}c and [Table 2](#t0010){ref-type="table"}), demonstrating that visual restoration could induce brain morphological changes at specific regions. Compared with the control group, significantly decreased GM volume was detected in the anterior cingulate gyrus at 1 week postoperatively (SI Appendix, Fig. S5a, SI Appendix, Table S4). However, no significant differences in GM volume were detected between the patients at 3 or 6 months postoperatively and the controls (SI Appendix, Fig. S5b, c, SI Appendix, Table S4). Collectively, these findings indicate that structural changes in the brains of cataract patients can be completely reversed after visual restoration.Fig. 4Comparison of brain GM volume in cataract patients before and after surgery. Surface maps show the changes in GM volume between preoperative and postoperative time points (at a whole-brain threshold of P \< 0·01, FDR corrected, voxels \> 200, repeated measures analysis of variance). Slice overlays and plots represent the mean signals from the smoothed difference images for each cluster. Significant differences in the signals are highlighted in the red circles. Blue and cyan reflect decreases. Red and yellow reflect increases, and *t* indicates the peak *t*-score value for the *t*-test. a, b, No significant difference in the GM volume signal was detected between the preoperative time point and the 1-week (a) or 3-month (b) postoperative time points. c, Compared with the preoperative values, the GM volumes observed at 6 months after surgery were significantly increased in the calcarine, fusiform, anterior/middle cingulate gyrus, inferior/middle frontal gyrus, inferior/medial orbitofrontal cortex, and precentral/postcentral gyrus. Notes: Mid, middle; Sup, superior; R, right; Frontal. Inf. Orb, inferior orbitofrontal cortex; Frontal. Med. Orb., medial orbitofrontal cortex.Fig. 4

3.6. Correlation Analysis Among Visual Function, Brain Function, and Brain Structure {#s0095}
------------------------------------------------------------------------------------

To investigate the relationship between the changes in the eye and brain, we performed a partial correlation analysis among visual function (changes in BCDVA, UCDVA, and PVEP), brain function (changes in the fALFF value before and 6 months after surgery), and brain structure (changes in the extracted GM volume before and 6 months after surgery), with age as a controlling factor. When the fALFF value was extracted from the superior parietal lobule \[L\] of each patient, a statistically significant negative correlation was observed between the change in the peak time of P100 and the change in the fALFF value (*P* = 0·035, *R* = 0·424). (SI Appendix, Fig. S6a and SI Appendix, Table S5). Furthermore, a positive correlation was observed between the change in the fALFF value (superior parietal lobule (L)) and the change in GM volume (frontal. Med. Orb (L) and calcarine (R)) (*P* \< 0·05) (SI Appendix, Fig. S6b, c, SI Appendix, Table S6). These findings indicated a close relationship among visual function, brain function, and brain structure.

4. Discussion {#s0100}
=============

The visual system and the brain seem to be more closely related than people ever thought. Previous studies have shown that cataract patients can present with an accelerated age-related decline in brain function ([@bb0190]; [@bb0105]). However, whether optical reconstruction after cataract surgery can enhance brain function and structure is unclear. The present study is the first to show that cataract patients with reduced visual function presented a simultaneous decrease in brain function and GM volume. Cataract surgery not only restored visual function but also significantly improved brain function and increased GM volume in both visual- and cognitive-related regions ([Fig. 5](#f0025){ref-type="fig"}).Fig. 5Improvements in brain structure and function in cataract patients after visual restoration. Six months after cataract surgery, the GM volumes of the following regions were increased to various extents: 1-fusiform (L) (BA20/36, *t* = 4·928), 2-frontal. Inf. Orb (R) (BA38/47, *t* = 6·433), 3-frontal. Inf. Orb (L) (BA47, *t* = 6·062), 4-frontal. Med. Orb (L) (BA10, *t* = 5·317), 5-anterior cingulate gyrus (R) (BA9/32, *t* = 6·395), 6-middle frontal gyrus (L) (BA6/8/9, *t* = 6·395), 7-middle frontal gyrus (R) (BA6/8/9, *t* = 5·393), 8-middle cingulate gyrus (R) (BA31, *t* = 5·020), 9-precentral gyrus (L) (BA6, *t* = 5·429), 10-precentral gyrus (R) (BA4, *t* = 4·960), 11-postcentral gyrus (L) (BA4, *t* = 4·600), 13-calcarine (R) (BA18/30, *t* = 5·055), 14-calcarine (L) (BA18/19/30, *t* = 5·052) and 15-superior temporal gyrus (L) (BA21/22, *t* = 6·159). The fALFF of the 12-superior parietal lobule (L) (BA17/19, *t* = 4·566) was increased after surgery, whereas the fALFF of the 16-brainstem (*t* = −3·923) was decreased. Notes: The sizes of the spots represent the degree of quantitative changes; GM, grey matter; fALFF, the fractional amplitude of low-frequency fluctuations; frontal. Inf. Orb, inferior orbitofrontal cortex; frontal. Med. Orb, medial orbitofrontal cortex; R, right; L, left.Fig. 5

Several studies have reported improvements in cognition after cataract surgery based on subjective questionnaire investigations ([@bb0200]; [@bb0100]; [@bb0140]). Hiroki Tamura and colleagues enrolled patients with cognitive impairment and compared their scores on the Revised Hasegawa Dementia Scale (RHD-S) before and after cataract surgery ([@bb0200]). A significant improvement was noted, from 12·5 ± 5·3 points to 16·6 ± 6·2 points, 3·65 weeks after surgery ([@bb0200]). Compared with the RHD-S, the MMSE is more suitable for cataract patients with visual impairments because it includes items evaluating reading and other visual-related abilities ([@bb0130]). In our study, significantly lower MMSE scores were observed in the cataract group (27·65 ± 1·47) compared with those in the control group (29·58 ± 0·86). Moreover, the MMSE scores were significantly increased at 3 and 6 months after cataract surgery. Specifically, the registration, recall, attention and calculation scores were all improved, which is consistent with previous findings ([@bb0100]). Nevertheless, repeated measurements of MMSE may result in being more familiar with questionnaire in cataract patients, leading to measurement bias, which should be interpreted with caution.

However, the subjective assessment of cognitive function under different pathophysiological conditions using the MMSE or other questionnaires has high inter-individual variation and lacks precision ([@bb0015]). A recent structural MRI study of unilateral cataract patients revealed that a regional expansion of GM volume occurs in the visual cortex area (V2) contralateral to the operated eye at 6 weeks after cataract surgery ([@bb0145]). However, the operation performed on unilateral cataract patients is not representative of an actual "sight restoration surgery", since the effects of visual restoration on visual cortex plasticity may be interceded by the relatively better visual acuity of the unoperated eye. Furthermore, the structural and functional alterations of other significant brain areas, such as the superior parietal lobule and anterior cingulate gyrus, after visual restoration remain unexplored. fMRI is a powerful tool for detecting subtle changes in the brain ([@bb0075]), and it can determine which brain regions are involved under critical conditions ([@bb0080]). For example, cognitively impaired elderly people show decreased ALFF values primarily in the posterior cingulate cortex, precuneus, and right lingual gyrus([@bb0135]) and exhibit neuropathological changes in the brain stem and limbic structures ([@bb0005]). The effect of congenital cataracts on the neural substrates of auditory processing was initially revealed in another study ([@bb0070]). In this study, we show that cataract surgery is associated with substantial changes in brain function and GM volume in adults. The observed fALFF and GM volume increases were primarily located in the superior parietal lobule, calcarine, anterior cingulate gyrus, postcentral gyrus, and precentral gyrus of the cerebral cortex. These regions play essential roles in vision processing and various other high-order functions, such as cognition ([@bb0025]), somatic movement, and somatosensory processing ([@bb0095]; [@bb0165]).

The mechanism underlying the alteration of brain function and structure after visual reconstruction has not been fully elucidated; however, gamma oscillations and photoreceptive retinal ganglion cells (pRGCs) have received increasing attention. Brain function can be directly affected by visual stimulation. For example, visual stimulation with a 40-Hz flicker elicits gamma oscillations in the visual cortex and reduces Aβ levels, which may have systemic effects on the brain and attenuate AD-related pathology ([@bb0090]). Moreover, pRGCs detect light and arouse physiological and neurobiological responses through the non-visual pathway. Impaired pRGC photoreception and the subsequent disturbance of light-induced, sleep-related hippocampal function may aggravate problems such as insomnia and cognitive deficits. Aged crystalline lenses prominently block blue light, which is the exact effective light (wavelengths below 500 nm) required for unconscious photoreception ([@bb0020]; [@bb0110]; [@bb0055]). Furthermore, patients with comorbid cognitive impairment and ARC tend to stay indoors, which exacerbates pRGC light deficiency and limits their exposure to beneficial visual stimuli. Therefore, patients with early cognitive impairment may benefit from early cataract extraction while their cooperation is still possible ([@bb0205]). In addition, cataract surgery may improve circadian photoreception, and IOLs that block only UV are more suitable than blue-blocking IOLs for improving cognition ([@bb0055]). However, further studies are required to dissect the molecular and cellular mechanisms underlying the improvements in brain function and structure after visual reconstruction.

In conclusion, our study demonstrated that the decline in visual function caused by ARC compromises brain function and structure and that these functional and structural changes can be reversed after cataract surgery. These findings provide further evidence that the integrity of the eye is essential for maintaining the function and structure of the brain within and beyond the primary visual pathway.
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